Intelligence Platform

Patents

Browse 76 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8399666

5-lipoxygenase-activating protein (FLAP) inhibitors

Panmira Pharmaceuticals, LLC · Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008038

Methods for determining oxygen concentration with protoporphyrin IX

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919621

Tricyclic inhibitors of 5-lipoxygenase

AMIRA PHARMACEUTICALS, INC. · Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7834037

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795274

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7347987

Inhibition of reactive oxygen species and protection of mammalian cells

The Regents of the University of Oklahoma · Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329401

Cyclooxygenase-2 selective agents useful as imaging probes and related methods

The Regents of the University of California · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7241571

Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis

The Regents of the University of California · Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101846

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060733

Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxyge

The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6953786

Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive ox

The Regents of the University of California · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6916843

Anti-inflammatory actions of cytochrome P450 expoxygenase-derived eicosanoids

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756399

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6730692

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6479546

Allosteric inhibitors of lipoxygenase

The Regents of the University of California · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462067

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6455541

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System · Granted Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6432918

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6407133

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen met

Maxim Pharmaceuticals, Inc. · Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen meta

Maxim Pharmaceuticals, Inc. · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242473

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6203991

Inhibition of smooth muscle cell migration by heme oxygenase I

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired